Sökning: "ökad medicinering"
Visar resultat 11 - 15 av 38 avhandlingar innehållade orden ökad medicinering.
11. Studies on Variability in Olanzapine Disposition
Sammanfattning : Schizophrenia and schizoaffective disorders are chronic conditions with a significant impact on many functions. Positive, negative, cognitive and motor symptoms appear in different degrees and constellations. Antipsychotics are of fundamental importance to reduce symptoms. LÄS MER
12. Chronic orofacial pain. Understanding patients from two perspectives : the clinical view and the patient's experience
Sammanfattning : Det övergripande syftet har varit att studera patienter med långvarig ansiktssmärta dels från ett kliniskt perspektiv och dels från patientens perspektiv. Samtliga patienter som ingått i studierna var remitterade till Tandvårdshögskolan i Malmö pga långvarig ansiktssmärta. LÄS MER
13. Effects of Ca2+, microRNAs, and rosuvastatin on insulin-secreting beta cell function
Sammanfattning : Type 2 diabetes (T2D) is a condition of high blood glucose levels due to insulin resistance and defective insulin secretion. Impaired insulin secretion plays a major role in the pathophysiology of T2D, it is mainly attributed to beta cell function i.e. failure to secrete insulin or reduced beta cell mass. LÄS MER
14. MANAGING DRUG USE IN THE ELDERLY. General practitioners’ adherence to guidelines and patients’ conceptions of medication
Sammanfattning : Introduction: Older patients’ knowledge about their medicines is generally poor. Patients are entitled to be informed on an individual and adequate level. LÄS MER
15. Depression in older people with and without dementia : non-pharmacological interventions and associations between psychotropic drugs and mortality
Sammanfattning : The aim of this thesis was to investigate associations between psychotropic drug use and death, associations between functional capacity, dependency in ADL and depression, and to evaluate a non-pharmacological intervention to reduce depressive symptoms, among older people with and without dementia.There is limited knowledge about the risk of death associated with psychotropic drug use among those aged ≥85 years, those with dementia, or those living in residential care facilities; groups that have a higher intake of psychotropic drugs and who are also more prone to adverse drug reactions. LÄS MER